Kardigan (KARD) shares surged 28% to $20.54 in their debut Thursday on the Nasdaq.
The clinical-stage precision therapeutics company priced its initial public offering of 25 million shares at $16 each. Underwriters were granted a 30-day option to purchase an additional 3.75 million shares.
The stock opened at $16.25 and rose as high as $21.
The offering is scheduled to close Monday.
Price: 20.54, Change: +4.54, Percent Change: +28.38
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.